HIV Sequencing After Treatment Interruption to Identify the Clinically Relevant Anatomical Reservoir
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Phase II Trial of Adjuvant Cisplatin and Radiation With Pembrolizumab in Resected Head and Neck Squamous Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study Evaluating the Pharmacokinetics of Doravirine (MK-1439) in Participants With Severe Renal Impairment (MK-1439-051)
- Status
- COMPLETED
- Phase
- PHASE1
Pembro and Vorinostat for Patients With Stage IV Non-small Cell Lung Cancer (NSCLC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Axitinib and Pembrolizumab in Subjects With Advanced Alveolar Soft Part Sarcoma and Other Soft Tissue Sarcomas
- Status
- COMPLETED
- Phase
- PHASE2
Pembrolizumab (MK-3475) in MM Patients With Residual Disease
- Status
- COMPLETED
- Phase
- PHASE2
Effectiveness and Safety Study of Fixed Versus Flexible of Gonadotropin-releasing Hormone Antagonist Protocol
- Status
- UNKNOWN
- Phase
- NA
Pembrolizumab and Chemoradiation Treatment for Advanced Cervical Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Pembrolizumab for HPV-associated Recurrent Respiratory Papilloma Patients
- Status
- COMPLETED
- Phase
- PHASE2
MK-3475 Immunotherapy in Endometrial Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Efficacy and Safety of Ertugliflozin in Asian Participants With Type 2 Diabetes and Inadequate Glycemic Control on Metformin Monotherapy (MK-8835-012)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Metronomic CP and JX-594 in Patients With Advanced Breast Cancer and Advanced Soft-tissue Sarcoma (METROmaJX)
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Safety and Efficacy of Doravirine, Tenofovir, Lamivudine (MK-1439A) in Participants Infected With Treatment-Naïve Human Immunodeficiency Virus (HIV) -1 With Transmitted Resistance (MK-1439A-030)
- Status
- COMPLETED
- Phase
- PHASE2
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Talimogene Laherparepvec With Pembrolizumab for Recurrent Metastatic Squamous Cell Carcinoma of the Head and Neck (MASTERKEY232 / KEYNOTE-137)
- Status
- COMPLETED
- Phase
- PHASE1
Study of Pembrolizumab (MK-3475) and Pembrolizumab With Other Investigational Agents in Participants With High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057)
- Status
- COMPLETED
- Phase
- PHASE2
Study Comparing Pembrolizumab With Dual MAPK Pathway Inhibition Plus Pembrolizumab in Melanoma Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Immune Response to Shingles Vaccination
- Status
- COMPLETED
- Phase
- PHASE4
Immunogenicity and Safety of Human Papilloma Virus Vaccine in Solid Organ Transplant Recipients
- Status
- COMPLETED
- Phase
- PHASE4
Remission Evaluation of a Metabolic Intervention in Type 2 Diabetes With Sitagliptin (REMIT-Sita)
- Status
- COMPLETED
- Phase
- PHASE3